Chromogranins: Clinical Trials

25 trials of Chromogranins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 2 terminated, 1 not yet recruiting, 1 withdrawn. 9 Phase 3, 7 Not applicable, 5 Phase 4, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 8, Terminated 1
Not applicable7Completed 6, Not yet recruiting 1
Phase 45Completed 4, Withdrawn 1
Phase 24Completed 3, Terminated 1

Follow Chromogranins: new trials by email Literature Review of Chromogranins trials Research Report on Chromogranins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Comparative Study of the Antibacterial Effects of Two Preoperative Hair Removal Methods in Male Patients With Urethral Stricture
Wiping with wet wipes containing 2% chlorhexidine gluconate (CHG). - Urethral Stricture
Not applicableNot yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine402026-04-012026-04-02
Effect of Bed Bathing Methods on VRE Colonization in ICU Patients
Bed Bath, Disposable antibacterial bed bath wipes, Chlorhexidine gluconate 4% - Vancomycin-Resistant Enterococcus
Not applicableCompletedÖzkan Kasap2102024-09-012026-05-07
Chlorhexidine to Prevent Catheter-related Urinary Tract Infection
Long Intervention, Mid-length Intervention, Short Intervention - Urinary Tract Infections
Not applicableCompletedNational Taiwan University Hospital309942023-03-012024-07-08
Randomized Controlled Trial Comparing Irrisept Versus Normal Saline for Wound Irrigation After Posterior Spine Surgery
saline 0.9%, (0.05% chlorhexidine gluconate (CHG) in sterile water) - Lumbar Spine Degeneration, Cervical Spine Degeneration
Phase 4WithdrawnUniversity of Missouri-Columbia2022-07-012022-12-27
Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis
Chlorhexidine Gluconate-gel (CHG) Dressing - Peritoneal Dialysis Catheter Exit Site Infection, End Stage Renal Disease on Dialysis
Not applicableCompletedNational Healthcare Group, Singapore302019-09-272023-09-05
Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery
ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG), Standard Wound Care - Cesarean Section Complications, Wound Breakdown
Phase 4CompletedThe University of Texas Medical Branch, Galveston1542019-04-182021-10-05
In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)
ZuraPrep Clear Solution, ChloraPrep, ZuraPrep Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.1562019-01-252023-02-08
Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures
10% povidone-iodine (1% free iodine) in purified water, 4% chlorhexidine gluconate (CHG) in purified water - Surgical Site Infection, Unplanned Fracture-Related Reoperation
Phase 4CompletedUniversity of Maryland, Baltimore16382018-04-082023-03-31
In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area
3M CHG/IPA Prep - Surgical Skin Preparation, Surgical Procedure, Unspecified
Phase 2CompletedSolventum US LLC282017-06-062024-10-02
Evaluation 2% Chlorhexidine Gluconate
2% CHG - Skin Coverage
Phase 2CompletedMedline Industries302016-11-162023-09-28
Clinical Evaluation of Patient Preoperative Prep
ZuraPrep, ChloraPrep, ZP Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.6402016-08-032021-07-16
In-vivo Efficacy of Patient Preoperative Prep
ZuraPrep, ChloraPrep, ZP Vehicle - Surgical Skin Preparation
Phase 3CompletedZurex Pharma, Inc.4402016-07-272023-02-08
Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle
ZuraPrep with 70% IPA, ZuraPrep without 70% IPA, ChloraPrep CHG/IPA Teal Tint - Surgical Site Infection
Phase 3CompletedZurex Pharma, Inc.1232015-10-012017-07-17
Effectiveness of Preoperative Surgical Scrubbing Using Clorhexidine Digluconate and Parachlorometaxylenol (ECP)
Preparatory handwash, Preoperative surgical scrubbing using 3% PCMX, Preoperative surgical scrubbing using 4% CHG - Skin Diseases, Surgical Site Infection
Not applicableCompletedRicardo Becerro de Bengoa Vallejo302015-06-012017-05-31
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)
ZuraPrep, ChloraPrep - Surgical Site Infection
Phase 2CompletedZurex Pharma, Inc.362014-11-012016-07-14
Preoperative CHG Cloth on Healthy Subjects
Chlorhexidine Gluconate, Vehicle, DynaHex-2 - Surgery
Phase 3CompletedMedline Industries8792014-10-012021-04-30
Evaluation of Two Hand Hygiene Products in ICUs
hand antiseptic with CHG and alcohol, Alcohol hand sanitizer foam - Hand Hygiene Effectiveness
Phase 4CompletedSolventum US LLC512014-10-012024-10-23
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™
Chloraprep, ZuraPrep, ZuraPrep Vehicle - Surgical Site Infection
Phase 2TerminatedZurex Pharma, Inc.642014-08-012016-07-18
In Vivo Efficacy Study of Patient Preoperative Preps
3M CHG/IPA Prep C, 3M CHG/IPA Prep CH, ChloraPrep - Bacterial Reduction Post-product Application
Phase 3Completed3M7382014-07-012020-11-23
Checklist to Prevent MRSA Surgical Site Infections
Mupirocin, Chlorhexidine gluconate, Cefazolin - Surgical Site Infection
Not applicableCompletedVA Office of Research and Development230052014-04-012026-03-31

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Surgical Wound Infection (8)  ·  Community-Acquired Infections (1)  ·  Fractures, Open (1)  ·  Kidney Failure, Chronic (1)  ·  Personal Satisfaction (1)  ·  Skin Diseases (1)  ·  Staphylococcal Infections (1)  ·  Staphylococcal Skin Infections (1)  ·  Surgical Wound Dehiscence (1)  ·  Urethral Stricture (1)  ·  Urinary Tract Infections (1)  ·  Wound Infection (1)

Sponsors

Zurex Pharma, Inc. (6)  ·  Solventum US LLC (4)  ·  Medline Industries (2)  ·  3M (1)  ·  C. R. Bard (1)  ·  Henry M. Jackson Foundation for the Advancement of Military Medicine (1)  ·  Johns Hopkins University (1)  ·  National Healthcare Group, Singapore (1)  ·  National Taiwan University Hospital (1)  ·  Ricardo Becerro de Bengoa Vallejo (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University of Maryland, Baltimore (1)  ·  University of Missouri-Columbia (1)  ·  VA Office of Research and Development (1)

Countries

United States (18)  ·  Canada (1)  ·  Romania (1)  ·  Singapore (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

M. Hamid Bashir, MD (2)  ·  Abhishek Deshpande, MD, PhD (1)  ·  Allen Yan Lun Liu (1)  ·  Antonio F. Saad, MD (1)  ·  Ayfer Ozbas, Prof.Dr. (1)  ·  C Beausoleil (1)  ·  Chris Beausoleil (1)  ·  Don Kim Moore, MD (1)  ·  Eli N. Perencevich, MD MS BS (1)  ·  Gerard Slobogean, MD (1)  ·  Hamid Bashir (1)  ·  Hong He (1)  ·  Jamie Miller, ADN (1)  ·  M H Bashir, MD (1)  ·  M. Hamid Barshir, MD (1)

Results publications

PMID 32131912, PMID 21028984, PMID 29382400, PMID 30334981, PMID 31737738, PMID 32259266, PMID 32787892, PMID 33264808, PMID 33618788, PMID 33648577, PMID 36244384, PMID 36925849, PMID 37471087

NIH funding

2019 (1)